IP Library › Granted Patent US 12,343,238
Granted Patent B2
US 12,343,238 · App. 17/777,955 · Granted Jul 1, 2025

Wound dressing comprising a combination of hydrogel and honey, method of preparation and uses thereof

Inventors: Daniel Lev (Western Galilee, IL); Yulia Holenberg (Ramat Hagolan, IL)
Assignee: Sion Biotext Medical Ltd.
A61F13/00063A61F13/01008A61K35/644A61L15/40A61L15/44A61L26/0009A61L26/008A61F2013/00161A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,238
App. No.
17/777,955
Granted
Jul 1, 2025
Kind
B2
Abstract

The present disclosure provides a wound dressing composition comprising cross-linked hydrogel scaffold and embedded therein anti-bacterially active honey, said activity being determined by the detection of hydrogen peroxide production rate by said wound dressing; said wound dressing further comprising at least one of a photo-initiator and/or at least one UV cross linker, the total amount of said photo-initiator and/or UV cross linker is equal or less than 0.2% w/w out of the total weight of the wound dressing. Also disclosed herein is a method of preparing the wound dressing and methods of using the same with respect to wounds, the method of preparation comprises mixing a hydrogel forming mixture comprising hydrogel forming monomer or monomers, honey and at least one photo-initiator and/or at least one UV cross-liker to form a homogenous mixture; and subjecting the homogenous mixture to UV irradiation until said homogenous mixture solidifies.

Claims (26)

1. A wound dressing composition comprising cross-linked hydrogel scaffold and embedded therein anti-bacterially active honey:

wherein the wound dressing composition has an anti-bacterial activity that is determined by a detection of hydrogen peroxide production rate by the wound dressing composition;

wherein the wound dressing composition further comprising at least one photo-initiator and at least one UV cross linker;

wherein a total amount of the at least one photo-initiator and the at least one UV cross linker is equal or less than 0.2% w/w out of a total weight of the wound dressing composition;

wherein an amount of the at least one UV cross linker does not exceed 0.15% w/w out of the total weight of the wound dressing composition; and

wherein the amount of the at least one photo-initiator and the at least one UV cross linker is effective to provide the wound dressing composition with no detectable amount of free monomer units.

2. The wound dressing composition of claim 1 , having a viscosity greater than 33,000 as determined by a viscometer using a T-Bar spindle at 12 rpm.

3. The wound dressing composition of claim 1 , wherein the cross-linked hydrogel is comprised of sulfonate containing monomeric units.

4. The wound dressing composition of claim 3 , wherein the sulfonate containing monomeric units comprises 2-Acrylamido-2-methylpropane sulfonic acid (AMPS).

5. The wound dressing composition of claim 1 , wherein the cross-linked hydrogel comprises hyaluronic acid (HA).

6. The wound dressing composition of claim 1 , comprising the anti-bacterially active honey in an amount of at least 5% w/w out of the total weight of the wound dressing composition.

7. The wound dressing composition of claim 1 , wherein the hydrogen peroxide production rate is determined by a use of a hydrogen peroxide strip test according to manufacturer's instruction.

8. The wound dressing composition of claim 1 , being embedded within or onto a support matrix.

9. The wound dressing composition of claim 1 , having a saline or water holding capacity of at least 700 w % from the weight of the wound dressing composition.

10. A method of treating a wound or preventing a wound infection, the method comprising placing a wound dressing composition of claim 1 , onto the wound.

11. A method of producing a wound dressing composition comprising cross-linked hydrogel scaffold and embedded therein anti-bacterially active honey, the method comprises:

mixing a hydrogel forming mixture comprising hydrogel forming monomer or monomers, anti-bacterially active honey, at least one photo-initiator and at least one UV cross linker to form a homogenous mixture; and

subjecting the homogenous mixture to UV irradiation until the homogenous mixture solidifies;

wherein a total amount of the at least one photo-initiator and the at least one UV cross linker is equal or less than 0.2% w/w out of a total weight of the wound dressing composition;

wherein an amount of the at least one UV cross linker does not exceed 0.15% w/w out of the total weight of the wound dressing composition; and

wherein the amount of the at least one photo-initiator and the at least one UV cross linker is effective to allow complete cross-linking of monomers of the cross-linked hydrogel.

12. The method of claim 11 , wherein said US the at least one UV cross linker comprises sulfonate-containing monomeric units.

13. The method of claim 11 , wherein the sulfonate containing monomeric units comprises or is AMPS.

14. The method of claim 11 , wherein the hydrogel forming mixture comprises hyaluronic acid (HA).

15. The method of claim 11 , wherein the anti-bacterially active honey is in an amount of at least 5% w/w out of the total weight of the wound dressing composition.

16. The method of claim 11 , comprising contacting the homogenous mixture with a supporting matrix prior to the UV irradiation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2022
From: LEV, DANIEL; HOLENBERG, YULIA
To: SION BIOTEXT MEDICAL LTD.
Reel/Frame 059950/0761 →
Priority Claims (1)
IL 270762 · Nov 19, 2019 · national
Continuity (1)
Related Publication 20230032299A1 · Feb 2, 2023
References Cited (60)
US 5065752A · Sessions et al. · 1991 [cited by applicant]
US 6162864A · Tanihara et al. · 2000 [cited by applicant]
US 6881789B2 · Bosse · 2005 [cited by applicant]
US 6956144B2 · Molan · 2005 [cited by applicant]
US 7511083B2 · Madsen et al. · 2009 [cited by applicant]
US 7714183B2 · Caskey · 2010 [cited by applicant]
US 8632810B2 · Moloney · 2014 [cited by applicant]
US 9107974B2 · Payne et al. · 2015 [cited by applicant]
US 9211358B2 · Sinko et al. · 2015 [cited by applicant]
US 11213569B2 · Hamed · 2022 [cited by examiner]
US 20030143274A1 · Viegas et al. · 2003 [cited by applicant]
US 20040153040A1 · Martineau et al. · 2004 [cited by applicant]
US 20110135726A1 · Munro et al. · 2011 [cited by applicant]
US 20140039423A1 · Riesinger et al. · 2014 [cited by applicant]
US 20140336557A1 · Durdag et al. · 2014 [cited by applicant]
US 20160339141A1 · Gann · 2016 [cited by applicant]
US 20170209500A1 · Moloney et al. · 2017 [cited by applicant]
US 20180110900A1 · Korenfeld · 2018 [cited by applicant]
US 20180161476A1 · MacDonald et al. · 2018 [cited by applicant]
US 20210069377A1 · Kershaw · 2021 [cited by examiner]
US 20210361492A1 · Wibaux · 2021 [cited by examiner]
CN 203577000U · 2014 [cited by applicant]
CN 108144109A · 2018 [cited by applicant]
CN 108404202A · 2018 [cited by examiner]
EP 1237561B1 · 2004 [cited by applicant]
EP 3351665A1 · 2018 [cited by applicant]
EP 3253424B1 · 2020 [cited by applicant]
GB 2322078A · 1998 [cited by applicant]
GB 2527617A · 2015 [cited by applicant]
KR 20190079073A · 2019 [cited by examiner]
RU 20140200A1 · 2015 [cited by examiner]
WO 2001015750A1 · 2001 [cited by applicant]
WO 2004089431A2 · 2004 [cited by applicant]
WO 2006037606A2 · 2006 [cited by applicant]
WO 2014074503A1 · 2014 [cited by applicant]
WO 2015059501A1 · 2015 [cited by applicant]
WO 2017147067A1 · 2017 [cited by applicant]
WO 2018050764A1 · 2018 [cited by applicant]
WO 2018091890A1 · 2018 [cited by applicant]
Translation of CN 108404202 A (Year: 2018). [cited by examiner]
Translation of RS 20140200 A1 (Year: 2015). [cited by examiner]
Translation of KR 20190079073 A (Year: 2019). [cited by examiner]
Mandal et al., Honey: its medicinal property and antibacterial activity, Apr. 2011, Asian Pacific Journal of Tropical Biomedicine, 1(2) :154-160, Abstract. (Year: 2011). [cited by examiner]
International Search Report and Written Opinion from International Application No. PCT/IL2020/051200 dated Feb. 22, 2021. [cited by applicant]
Oryan et al., “Biological properties and therapeutic activities of honey in wound healing: A narrative review and meta-analysis” Journal of Tissue Viability (2016) 25(2), 98-118. [cited by applicant]
Abu-Jdayil et al., “Heat effect on rheology of light- and dark-colored honey” Journal of Food Engineering 51(1), 33-38. [cited by applicant]
Biluca et al., “5-HMF and carbohydrates content in stingless bee honey by CE before and after thermal treatment” Food Chemistry (2014) 159, 244-249. [cited by applicant]
Dag et al., “Physical, chemical and palynological characterization of avocado ( [cited by applicant]
Petrov, V. “Mineral constituents of some Australian honeys as determined by atomic absorption spectrophotometry”. Journal of Apicultural Research (1970) 9, 95-101. [cited by applicant]
Da Silva et al. “Honey: Chemical composition, stability and authenticity” Food Chemistry (2016) 196, 309-323. [cited by applicant]
Henriques et al. “Free radical production and quenching in honeys with wound healing potential” Journal of Antimicrobial Chemotherapy (2006) 58, 773-777. [cited by applicant]
Nalampang et al “Design and Preparation of AMPS-Based Hydrogels for Biomedical Use as Wound Dressings” Chiang Mai J. Sci. (2007) 34(2), 183-189. [cited by applicant]
Golon et al., “Characterization of “caramel-type” thermal decomposition products of selected monosaccharides including fructose, mannose, galactose, arabinose and ribose by advanced electrospray ionization mass spectrom… [cited by applicant]
Simkovic et al., “Primary reactions of sucrose thermal degradation” J. Anal. Appl. Pyrolysis (2003) 70, 493-504. [cited by applicant]
Sohaimy et al., “Physicochemical characteristics of honey from different origins” Annals of Agricultural Sciences (2015) 60 (2), 279-287. [cited by applicant]
Durmaza et al., “Acrylamide/2-acrylamido-2-methylpropane sulfonic acid sodium salt-based hydrogels: synthesis and characterization” Polymer (2000) 41, 3693-3704. [cited by applicant]
Oroian et al., “Multi-Element Composition of Honey as a Suitable Tool for Its Authenticity Analysis” Pol. J. Food Nutr. Sci., (2015) 65(2), 93-100. [cited by applicant]
White Jr. JW “Honey” Advances in Food Research (1978) 24, 287-374. [cited by applicant]
Al-Waili et al., “Honey for wound healing, ulcers, and burns; Data Supporting Its Use in Clinical Practice”, The Scientific World Journal (2011) 11, 766-787. [cited by applicant]
El-Kased et al. “Honey-based hydrogel: In vitro and comparative In vivo evaluation for burn wound healing”, Scientific Reports, 7-9692, pp. 1-11. [cited by applicant]